Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z.

J Infect Dis. 2009 Dec 15;200(12):1874-83. doi: 10.1086/648405.

PMID:
19909080
2.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiń≠ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
3.

Influenza A viruses: why focusing on M2e-based universal vaccines.

Ebrahimi SM, Tebianian M.

Virus Genes. 2011 Feb;42(1):1-8. doi: 10.1007/s11262-010-0547-7. Epub 2010 Nov 17. Review. Erratum in: Virus Genes. 2011 Feb;42(1):9.

PMID:
21082230
4.

A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.

McMurry JA, Johansson BE, De Groot AS.

Hum Vaccin. 2008 Mar-Apr;4(2):148-57. Epub 2007 Oct 14. Review.

PMID:
18382131
5.

Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.

Lynch GW, Selleck P, Church WB, Sullivan JS.

Immunol Cell Biol. 2012 Feb;90(2):149-58. doi: 10.1038/icb.2011.38. Epub 2011 Jun 7. Review.

PMID:
21647170
6.

Correlates of protection: novel generations of influenza vaccines.

Rimmelzwaan GF, McElhaney JE.

Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. Review.

PMID:
19230158
7.

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD.

Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Review.

PMID:
20021306
8.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
9.

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Curr Opin Biotechnol. 2007 Dec;18(6):529-36. Review.

PMID:
18083548
10.

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

Tamura S, Kurata T.

Jpn J Infect Dis. 2004 Dec;57(6):236-47. Review.

11.

Development of a vaccine against pandemic influenza viruses: current status and perspectives.

Ilyinskii PO, Thoidis G, Shneider AM.

Int Rev Immunol. 2008;27(6):392-426. doi: 10.1080/08830180802295765. Review.

PMID:
19065349
12.

One step closer to universal influenza epitopes.

Li OT, Poon LL.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):687-90. doi: 10.1586/eri.09.48. Review.

PMID:
19681695
13.

[Development of attenuated H5N1 avian influenza vaccines using reverse genetic technology].

Odagiri T.

Nihon Rinsho. 2006 Oct;64(10):1855-64. Review. Japanese.

PMID:
17037360
14.
15.

Pandemic preparedness: toward a universal influenza vaccine.

Roose K, Fiers W, Saelens X.

Drug News Perspect. 2009 Mar;22(2):80-92. doi: 10.1358/dnp.2009.22.2.1334451. Review.

PMID:
19330167
16.

[Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines].

Merkulov VA, Lebedev VN, Plekhanova TM, Maksimov VA, Korovkin SA, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr;(2):111-7. Review. Russian.

PMID:
19462520
17.

Vaccination of birds other than chickens and turkeys against avian influenza.

Koch G, Steensels M, van den Berg T.

Rev Sci Tech. 2009 Apr;28(1):307-18. Review.

PMID:
19618634
18.

A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.

Stech J, Klenk HD.

Berl Munch Tierarztl Wochenschr. 2006 Mar-Apr;119(3-4):186-91. Review.

PMID:
16573209
19.

Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.

Wong JP, Christopher ME, Viswanathan S, Dai X, Salazar AM, Sun LQ, Wang M.

Curr Pharm Des. 2009;15(11):1269-74. Review.

PMID:
19355966
20.

Experiences with vaccination in countries endemically infected with highly pathogenic avian influenza: the Food and Agriculture Organization perspective.

Domenech J, Dauphin G, Rushton J, McGrane J, Lubroth J, Tripodi A, Gilbert J, Sims LD.

Rev Sci Tech. 2009 Apr;28(1):293-305. Review.

PMID:
19618633

Supplemental Content

Support Center